. Secondary structure analysis, related to Figure 1. Although firefly luciferase and the two click beetle luciferases exhibit only 47.1% amino acid homology, this plot shows the high level of secondary structure homology. Click beetle green and click beetle red exhibit 98.5% amino acid homology. All of these luciferase isotypes require D-luciferin as a substrate. The Garnier-Robson plot was performed using PROTEAN. The "overlap region" is located at both the N and C termini of the C and N fragments of the luciferase complementation constructs, respectively.
HEK293T were batch co-transfected with different luciferase PCA fusion pairs and incubated for 48 hours. Cells were then washed with PBS and treated with 100 nM rapamycin or vehicle with simultaneous addition of increasing concentrations of Dluciferin for 6 hours. Cells were then washed with PBS and imaged in MEBSS with 1% serum containing 150 g/ml D-luciferin to determine apparent rapamycin-mediated induction of FRB-FKBP complex formation. This experiment demonstrated that at concentrations of D-luciferin typically used for bioluminescence experiments (10-1000 M), interactions of the luciferase PCA reporters were not affected by the D-luciferin concentration nor was D-luciferin acting as a luciferase PCA dimerization agent per se. Thus, the concentration ranges of D-luciferin used in most experiments produced no difference in fold-inducibility. However, at very high, non-pharmacological levels of Dluciferin (10 mM), the rapamycin-untreated cells also showed apparent induction of FRB-FKBP complex formation, perhaps evidence for D-luciferin-mediated basal complementation of the luciferase fragments, resulting in a decrease in overall inducibility. CHO TetON cells in 96-well plates were transfected for 24 hours with plasmids expressing the EGFR-CBG fusion constructs. Imaging was performed following serum starvation for 3 hours, to ensure responsiveness to EGF stimulation. A) Untreated, B) Drug vehicle (DMSO), or C) 10 µM U0126 plus D-luciferin were added to cells and then plates were incubated in an IVIS chamber for 20 minutes for thermal equilibration, followed by 10 minutes of sequential imaging to establish baseline signal intensity. EGF (25 nM) (B and C) or EGF vehicle (media; A) was then added to the media to initiate activation of EGFR, followed by sequential imaging for 20 minutes. Raw photon flux data are plotted as a function of time.
Error bars represent ± SEM (n=8). 
Figure S9. Imaging drug-induced protein interactions in vivo
A) Mouse livers were transfected with plasmids encoding the indicated luciferase reporter fragments as well as RLuc using the hepatocellular hydrodynamic somatic cell transfection technique. Mice were imaged prior to treatment (pre), then administered rapamycin (1 mg/kg) (shown) or vehicle and re-imaged 6 hours later (post). B) Representation of all individual mice imaged (n= 24) and the group mean (inset) for overall photon outputs versus fold-induction (post treatment/pre treatment) of each construct tested; 1 mg/kg rapamycin (solid symbols) or vehicle (open symbols). Photon flux within ROIs was normalized to RLuc to account for differences in somatic cell transfection efficiencies; fold-induction was calculated as post-treatment photon flux divided by pre-treatment photon flux.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Development of anti-click beetle luciferase antibody A primary polyclonal antibody for detecting click beetle luciferase was developed using SKGYVNNVEATKEAIDDDG as the antigen. The sequence is found in all intact and click beetle luciferase PCA fragments, but not firefly luciferase. The final antiserum was isolated from the second bleed of rabbit #2 housed at a commercial vendor (Invitrogen Corporation). The serum was fractionated over an Ig column and the KSCN eluant recovered for use as the final antiserum without further purification.
Drug titration curves in cellulo
HEK293T cells (1x10 4 cells per well) were transfected with 75 ng of each luciferase PCA plasmid pair and allowed to incubate for 48 hours in DMEM with 10% ΔFBS and 1% glutamine. Cells were then treated with increasing concentrations of rapamycin for 6 hours. For the FK506 inhibition assays, 10 nM rapamycin was added to cells along with increasing concentrations of FK506 as indicated for 6 hours to inhibit rapamycin-induced interactions. Cells were then gently washed with PBS and imaged using MEBSS with 1% serum and 150 g/ml of D-luciferin. Live cells were imaged in an IVIS 100 at 37ºC using the open filter. All experiments were performed in quadriplicate. Titration data were fitted by nonlinear regression to a standard fourparameter single-site binding equation to yield K d and K i values (GraphPad Prism, La Jolla, CA).
D-Luciferin concentration curves in cellulo
HEK293T cells (1x10 4 cells per well) in 100 l of DMEM supplemented with 10% ΔFBS and 1% glutamine were transfected with 75 ng of each luciferase PCA plasmid plus 5 ng of RLuc plasmid (for normalization) using 450 nl of Fugene6 transfection reagent, at a 3:1 Fugene:DNA ratio, in 96-well plates. Cells were incubated for 48 hours at which point 100 l of media containing rapamycin or vehicle and increasing concentrations of D-luciferin were added. Cells were incubated for 6 hours, washed with PBS, and then imaged in MEBSS with 1% serum and 150 g/ml D-luciferin in an IVIS 100 (Supplemental Figure S4 ).
Imaging reversibility of FRB-FKBP protein interactions with luciferase PCA in cellulo
HEK293T cells (1 x 10   4 per well of a 96-well plate) were transfected with a total of 150 ng of PCA plasmids (75 ng each of CBG-C fusion plus either CBG-N or CBG-N (S2035I) fusions) using 3:1 Fugene6:DNA ratios for batch transfections. After 48 hours, cells were washed with PBS and imaged in DMEM imaging media (DMEM minus phenol, containing 10% ΔFBS, 1% L-glutamine, and 150 g/ml D-luciferin). First, rapamycin (10 nM) or vehicle (DMSO) were added to the media, and cells were immediately imaged sequentially for 150 min. Then, FK506 (10 M final concentration) or vehicle (DMSO) were added to wells and imaging continued for an additional 325 min. In experiments involving inhibition of translation, rapamycin (10 nM) or vehicle (DMSO) were added to the media and cells were incubated for 5 hours. Then, cycloheximide (final concentration, 100 µM) or vehicle (DMSO) were added to the wells and imaged for 1.5 hours. Finally, FK506 (final concentration, 10 M) or vehicle (DMSO) were added to the wells and imaging continued for an additional 6.5 hours. Live cells were imaged using the IVIS 100 system at 37ºC (f-stop, 1; FOV, 15cm; binning, 8; exposure time 1 min; open filter) modified to allow continuous flow of 5% CO 2 in 95% air. Photon flux data were expressed as fold-rapamycin treated/vehicle treated.
Imaging reversibile protein conformations of EGFR with CBG luciferase PCA in cellulo CHO-K1 TetOn cells (Clontech) were maintained in high glucose DMEM with 10% ΔFBS and 1% L-glutamine. Cells (10,000 per well) were seeded into a black 96 well assay plate in a volume of 150 l. Cells were incubated for 24 hours until they were greater than 95% confluent. For transfection of plasmids bearing EGFR-CBG-N and EGFR-CBG-C expression cassettes (200 ng each plasmid), lipofectamine 2000 (Invitrogen) in Opti-MEM reduced-serum media was used according to the manufacturer's specifications. Transfection was allowed to proceed for 3 hours and then the media was removed and replaced with fresh serum-containing media. Cells were incubated for 24 hours before analysis. For the assay, media was removed and cells were rinsed in serum-free DMEM and then incubated in 150 l of serum-free DMEM for 3 hours prior to the imaging as described (Yang et al., 2009) . After 3 hours, media was replaced with 175 l of imaging media (DMEM without phenol, containing BSA (1 mg/ml), HEPES (25 mM), and D-luciferin (600 µg/ml)). At this time, recombinant mouse EGF was diluted to 200 nM in imaging media such that 25 l could be added to each well (final concentration, 25 nM). The diluted EGF stock was placed in a 37°C water bath until needed. Also at this time, 5 l of a 400 M solution of U0126 in imaging media was added to appropriate wells (final concentration, 10 M). An equivalent amount of DMSO was diluted in imaging media and 5 l was added to the appropriate wells to serve as vehicle control for the MAPK inhibitor. As a control, the off-target drug SB-216763 (a GSK3β inhibitor; final concentration, 10 M ) also was added to appropriate wells. Assay plates were placed into the IVIS chamber and incubated for 20 minutes for thermal equilibration. Next, baseline signal was imaged for 10 minutes in an IVIS100 imaging system (f-stop, 1; FOV, 15 cm; binning, 8; exposure time, 15 sec; open filter). Immediately thereafter, pre-warmed imaging media alone was added to the appropriate wells to serve as a vehicle control for the EGF addition, or the pre-diluted and warmed EGF solution was added to the DMSO-and drug-containing wells using a multi-channel robotic pipet. Imaging sequences were re-started immediately and analyzed as above. Raw data are shown in Supplemental Figure S5 . Data in Figure 4 are presented as change in photon flux (photons/sec) by subtraction of initial (t = 0) values.
Spectral deconvolution of multi-color luciferase PCA in cellulo
HEK293T cells were co-transfected with differing ratios of luciferase PCA pairs using DNA ranging from 100% to 0% in 20% intervals (0, 20, 40, 60, 80 , 100 ng for each fragment) in a 96-well plate format. For the combination of FLuc and CBG PCA, 200 ng total DNA per well were aliquotted in different ratios. For click beetle luciferase PCA pairs, an equal amount of CBG-C (100 ng) was plated in each well. All cells were transfected using Fugene6 transfection reagent and allowed to incubate for 48 hours. All cells were treated with 100 nM rapamycin for 6 hours and subsequently washed briefly with PBS. Cells were then incubated in colorless MEBSS with 1% serum and 150 g/ml D-luciferin and imaged at 37°C in an IVIS 100 using open, 540AF20 band pass, and 650A long pass filters in rapid succession. Images were then spectrally unmixed using the Biolumunmix v.1.0 software plug-in on ImageJ (Gammon et al., 2006) .
Bioluminescent imaging of mice in vivo
Animal protocols were approved by the Animal Studies Committee at Washington University School of Medicine. 15 g of each luciferase PCA plasmid (30 g total) and 2 g of RLuc plasmid were injected intravenously into mice in a volume of Solution A (Gibco) equaling 10% of the mouse body weight. The DNA mixture was injected via bolus tail vein injection within 5 sec to properly transfect the liver via hydrodynamic somatic gene transfer (Pichler et al., 2005) . Mice were then allowed to recover for 16-24 hours prior to imaging. D-luciferin was injected i.p. at 150 mg/kg body weight to generate a pre-treatment FLuc image. Rapamycin (1 mg/kg) was then injected i.p. to induce protein interactions or vehicle control. 4 hours after D-luciferin injections, coelenterazine was injected i.v. at 1 mg/kg body weight and mice imaged for Rluc activity to enable normalization of total FLuc photon flux for transfection efficiency. The coelenterazine signal decayed to background levels within 1 hour. Then, 6 hours after the initial rapamycin injection and 2 hours after RLuc imaging, 150 mg/kg D-luciferin was re-injected i.p. and mice imaged to measure post-treatment FLuc photon flux. All mice were imaged at 37ºC in an IVIS 100 system (open filter; FOV, 15 cm; f-stop, 1; binning, 4; exposure time, 60 sec). Regions of interest (ROI) were defined manually over liver images for determining total FLuc photon flux (photons/sec). Data were expressed as fold-induction (post-treatment/pre-treatment).
SUPPLEMENTAL RESULTS AND DISCUSSION

Characterization and validation of complementation fragments
The rapamycin-binding domain of human mTOR (residues 2024-2113; FRB) and human FK506-binding protein-12 (FKBP) provided a well-characterized macromolecular interaction platform to validate the new protein fragment complementation pairs (Chen et al., 1995; Luker et al., 2004) . The N-termini fragments of all luciferase PCA constructs were each fused to a flexible G-S linker and the C-terminus of FRB, while the C-termini fragments of all constructs were each fused to a flexible G-S linker and the N-terminus of FKBP ( Figure 1A ). Protein interactions interrogated by luciferase protein fragment complementation were analyzed by live cell bioluminescence imaging. Additionally, assays were normalized for transfection efficiency and cell viability by co-transfection of intact Renilla luciferase, and imaged using a distinct substrate, coelenterazine. In general, normalized photon flux data expressed as a ratio of luciferase PCA-induced signal over Renilla luciferase signal from each well ( Figure 1B ) correlated highly to data sets analyzed as luciferase PCA-induced signal alone (Supplemental Figure S2) ; most experiments were normalized for transfection efficiency or protein content.
Characterization of FRB-FKBP interactions with various luciferase PCA pairs showed that different combinations of PCA fragment pairs yielded several novel PCA combinations with a variety of photon flux and spectral characteristics ( Figure 1C, D) . When FRB-FKBP interactions were induced by treatment with rapamycin for 6 hours, Ntermini of both CBR and CBG exhibited paired functionality with any C-terminal fragment, but most efficiently with the respective homologous click beetle C-termini. The inset of Figure 1B is presented in log scale to better illustrate that combinations of the N-terminus of either CBG or CBR with the C-terminus of firefly luciferase yielded low, but significant photon flux (~4 fold over background). However, firefly luciferase N-termini yielded no signal when paired with any click beetle luciferase C-termini. Figure 1D compares the total photon flux of the paired constructs in the presence of rapamycin versus spectrum of emission as characterized by the red/green ratio (photon flux >590 nm/photon flux between 500-570 nm). Paired CBG and CBR homoprotein fragments retained the original spectral characteristics of the intact parent protein; however, when combined with firefly luciferase C-termini, the spectral emission characteristics as determined by red/green ratios tended to drift towards that of firefly luciferase. As previously reported (Luker et al., 2004) , firefly luciferase PCA also had no change in color as compared to its intact counterpart. However, the emission color of all heteroprotein pairings demonstrated a clear dependency on the identity of the N-terminus ( Figure 1D ).
Spectral deconvolution
Separation of color using a bioluminescence spectral deconvolution algorithm enables accurate quantification of multi-colored luciferase reporters (blue vs. green vs. red) within the same region of interest (Gammon et al., 2006) . To resolve two sets of protein interaction pairs in the same cells simultaneously, HEK293T cells in a 96-well plate format were co-transfected with concentration gradients of plasmids expressing CBG, CBR and FLuc luciferase PCA systems as indicated (Supplemental Figure S6) , each fragment fused to FRB or FKBP as above. Photon fluxes from the different fusion fragment combinations in live cells treated with rapamycin were spectrally resolved by acquiring an unfiltered (full spectrum) image and two filtered images (540 ± 20 nm; >650 nm) in rapid succession followed by analysis with Biolumunmixing v.1.0, an ImageJ software application (Gammon et al., 2006) . Supplemental Figure S6 shows the spectral images and calculated deconvolution data from live cell imaging. The top row of plate images in Supplemental Figure S6A illustrates the open filter image as well as deconvoluted green and deconvoluted red images (subpanels 1, 2, and 3, respectively) from opposing gradients of FLuc-N/FLuc-C and CBG-N/CBG-C fusion constructs cotransfected into the same cells across the plate (all eight rows). Spectral deconvolution easily separated the two sets of simultaneously interacting proteins within the target cells (Supplemental Figure S6B ). Under these conditions, note that FLuc-N would not complement CBG-C, and conversely, the photon flux from CBG-N complementing FLuc-C would represent only ~1% of the photon flux emitted from the complementation of the homologous CBG-N/CBG-C pair (see Figure 1B) . The bottom row of plate images in Figure Supplemental S6A illustrates the open filter, deconvoluted green and deconvoluted red images (subpanels 4, 5, and 6, respectively) from simultaneous opposing gradients of CBR-N and CBG-N fusions co-transfected with a constant amount of CBG-C fusion into the same cells (all eight rows). Deconvolution analysis readily separated rapamycin-induced FRB-FKBP interactions tagged with CBR-N/CBG-C (red) from those tagged with CBG-N/CBG-C (green) within the same cells (Supplemental Figure S6C) . In effect, this demonstrated the quantitative imaging of a red/green protein interaction switch in live cells.
Imaging pharmacodynamics in live animals in vivo
To characterize the efficacy of the luciferase PCA reporters for non-invasive monitoring of rapamycin-induced protein-protein interactions in vivo, plasmids encoding the luciferase PCA fusion fragments and RLuc were delivered to mouse hepatocytes using a high volume hydrodynamic somatic cell gene transfer technique (Pichler et al., 2005) . Hepatocellular transfection is the most stringent test for assessment of optical techniques in vivo due to the inherent optical opacity of the liver (Zhao et al., 2005) . In vivo imaging data showed high levels of variability between mice, but overall, when normalized by transfection efficiency (RLuc), CBG luciferase PCA exhibited the greatest level of total photon flux and fold-induction in vivo upon systemic injection of rapamycin (Supplemental Figure S9A, B) . While CBR luciferase PCA showed comparable levels of normalized photon flux, the fold-inducibility in vivo (5-fold) was substantially lower than observed in cellulo (up to 20-fold), thus hindering its usefulness in vivo (Supplemental Figure S9B) . The original firefly luciferase PCA pair showed both excellent foldinduction and photon flux, but was surpassed by the CBG luciferase PCA pairs under these matched conditions in vivo (Supplemental Figure S9A, B) . This illustrated that while the red-shifted emission spectra of CBR and FLuc should decrease photon attenuation by tissue in vivo, total detectable photon flux is a combination of tissue attenuation, protein expression levels, reconstitution efficiency and total enzymatic activity and thus, the overall biochemical properties of CBG luciferase PCA surpassed the more favorable red spectra of FLuc and CBR fragments in these experiments. While there remains room for further confirmation, this suggested that despite a hypothetical disadvantage of emission in the green region of the spectrum, CBG luciferase PCA fusions may be the overall best pair for use in vivo.
Comparison to Fluorescence
Various fluorescent proteins also have been designed as PCA reporters (Cabantous et al., 2005; Cabantous and Waldo, 2006; Ghosh et al., 2000; Ozawa et al., 2000; Wilson et al., 2004) , including a fluorescent protein system yielding blue, cyan, green and yellow colors (Hu and Kerppola, 2003) . These PCA systems also allow simultaneous imaging of multiple protein interactions within cells as well as differential compartmentalization. Several advantages of fluorescent proteins over bioluminescent reporters include the lack of a substrate, sufficient signal for high throughput analysis via FACS, and subcellular localization measurements via microscopy. However, since maturation of fluorescent proteins involves covalent rearrangement of bonds within the fluorophore inside the -barrel of the protein, once formed and matured (Tsien, 1998) , fluorescent protein PCA systems do not stop fluorescing until the intact fusion proteins are degraded. This limits the utility of fluorescent protein PCA systems for real-time assays and quantitative biochemical titration analysis of reversible protein complexes because on-reactions are kinetically delayed by the maturation process and off-reactions are in principle impossible to detect (Michnick et al., 2007) . In contrast, excitation-free analysis with luciferase reporters may enhance the ability of bioluminescence to monitor protein interactions continuously over time and without the complexities of photobleaching or laser-induced cell damage. In addition, with fluorescence, both the excitation as well as the emission light experience scattering. This is not the case in bioluminescence, which may enhance applications in cellulo and in vivo.
